I-Vasc Srl Announces Achievement Of 1,8M € Series A Investment To Launch Its Product, Velex™, A Device For The Treatment Of Chronic Venous Insufficiency (Cvi)
I-Vasc Srl Announces Achievement Of 1,8M € Series A Investment To Launch Its Product, Velex™, A Device For The Treatment Of Chronic Venous Insufficiency (Cvi)
04/08/22, 6:00 AM
Location
milanRound Type
series a
The Series A round has seen the participation of former shareholders and a significant contribution of new investors: Italian business angels, family office and others. I-VASC is planning to use the proceeds from this round to execute post-market clinical studies, to obtain FDA approval for the US market and complete product industrialization.
Company Info
Location
milan, lombardy, italy
Additional Info
In addition to the 750K Euro tranche raised in the first half of 2021, the company has raised another 1.066M Euro tranche before the end of last year, for a total amount of 1.8M Euro in 2021. The company has also announced the appointments of two new Directors in its board to reinforce its management Team in this phase of strategic growth: Daniele Zanotti, who has assumed the role of CEO, and Cristiano Fontana, who has undertaken responsibility for business development, marketing and communication.